Seeking Alpha

Sarepta Therapeutics (SRPT) receives a stop-work order for its Ebola virus therapeutics from the...

Sarepta Therapeutics (SRPT) receives a stop-work order for its Ebola virus therapeutics from the U.S. Department of Defense due to budget constraints. The order will remain in effect until September 1, when a final decision will be made on the ultimate future of the program. Shares -3.2% AH.
Comments (1)
  • aikifredicist
    , contributor
    Comment (1) | Send Message
     
    DoD spending cutbacks zap another program...
    4 Aug 2012, 04:01 AM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|